Business context and reporting period
The supplied filing is ESGEN Acquisition Corporation’s unaudited Form 10-Q for the quarter ended June 30, 2023, filed August 14, 2023. It is a special purpose acquisition company (SPAC) that had not begun operating a business and reported no operating revenue. This does not match the request metadata identifying Zeo Energy Corp.; the filing instead describes a proposed combination with Sunergy Renewables, LLC.
Financial highlights
| Metric | Three months ended June 30, 2023 | Six months ended June 30, 2023 |
|---|---|---|
| Operating costs | $1.82 million | $3.34 million |
| Net loss | $1.41 million | $2.86 million |
| Trust-account interest income | $365,224 | $1.31 million |
| Operating cash flow | $920,607 provided in the first half |
- At June 30, cash outside the trust was $50,193; trust-account marketable securities were $31.63 million. Total assets were $31.70 million.
- Current liabilities were $5.63 million, including $4.66 million of accounts payable and accrued expenses, $279,193 due to related parties, and a $687,208 related-party promissory note. Shareholders’ deficit was $7.62 million.
- No conventional revenue or operating margin was reported. The company had no long-term debt obligations; its related-party notes were unsecured and non-interest-bearing.
Material changes versus the prior comparable period
- Second-quarter net results shifted from $1.49 million income in 2022 to $1.41 million loss in 2023. First-half results shifted from $7.38 million income to $2.86 million loss. Prior-year income was substantially affected by warrant-liability fair-value gains, while 2023 included warrant-liability losses and higher operating costs.
- First-half legal and professional fees rose to $3.04 million from $791,522 in 2022. Trust-account interest increased to $1.31 million from $386,945.
- Following the January 2023 extension vote, 24,703,445 public shares were redeemed for approximately $255.88 million, leaving 2,896,555 redeemable Class A shares at quarter-end, down from 27.6 million at year-end 2022.
- In April 2023, underwriters waived the $9.66 million deferred underwriting commission. The filing reports a $425,040 recovery of offering costs and a $9.23 million adjustment to accumulated deficit.
Outlook, risks, contingencies and unusual items
- ESGEN signed a business combination agreement with Sunergy Renewables on April 19, 2023. The transaction was expected to close in the fourth quarter of 2023, subject to shareholder approval and other conditions. A $10 million sponsor PIPE investment was committed contingent on closing; additional financing was being sought. Transaction proceeds must meet a $20 million minimum condition.
- The company’s then-current deadline to complete a business combination was August 22, 2023, with possible monthly extensions subject to sponsor funding. Failure to complete a transaction or obtain an extension would trigger liquidation. Management stated that substantial doubt existed about the company’s ability to continue as a going concern.
- Management said available outside-trust cash and borrowing capacity would not be sufficient to meet needs through the earlier of a combination or one year from filing. It also disclosed that the sponsor was not obligated to provide additional working-capital loans.
- Disclosure controls were reported ineffective because a previously identified material weakness persisted, involving insufficient accounting and internal-control expertise and controls over earnings-per-share calculations and trust-account cash-flow classification.
- The filing cites economic uncertainty related to the Russia-Ukraine conflict. It reports no legal proceedings and no material market or interest-rate exposure as of June 30.
Important facts for investors to verify
- Confirm the intended issuer: this filing is for ESGEN Acquisition Corporation, not Zeo Energy Corp.
- Check subsequent filings for the status and final terms of the Sunergy transaction, required approvals, financing, redemptions, and any extension or liquidation.
- Reconcile related-party amounts: the balance sheet components total $966,401, while MD&A elsewhere says $996,401.
- Reconcile warrant liabilities: the balance sheet reports $2,049,024, while the fair-value table totals $1,948,800.
- Review the remediation of the disclosed material weakness and whether the control deficiencies were resolved in later reports.